Showing results (51-60 of 223) with videos related to
Sort By:
Pageof 23
Beneficial Microbes|July 29, 2021
A critical evaluation of the factors affecting the survival and persistence of beneficial bacteria in healthy adultsL Morelli, P PellegrinoJournal of Immunology (Baltimore, Md. : 1950)|December 15, 1993
Triggering of the cytotoxic activity of murine natural killer and lymphokine-activated killer cells through the NK2.1 antigenL Morelli, S LemieuxJournal of Medical Microbiology|September 1, 1996
Correlation of SfiI macrorestriction endonuclease fingerprint analysis of Candida parapsilosis isolates with source of isolationE Pontieri, L Gregori, M Gennarelli, et al.Scandinavian Journal of Immunology|January 1, 1993
Idiotypic vaccination: immunoprotection mediated by anti-idiotypic antibodies with antibiotic activityL Polonelli, R Lorenzini, F De Bernardis, et al.Nature Biotechnology|February 1, 1997
Therapeutic potential of antiidiotypic single chain antibodies with yeast killer toxin activityW Magliani, S Conti, F de Bernardis, et al.The Journal of Antibiotics|March 1, 1995
Structure activity studies on chemically modified homologues of the antibiotic phytotoxic leucinostatin AG Vertuani, M Boggian, A Scatturin, et al.The Journal of Infectious Diseases|June 1, 1990
Evidence for a role for secreted aspartate proteinase of Candida albicans in vulvovaginal candidiasisF De Bernardis, L Agatensi, I K Ross, et al.Infection and Immunity|February 1, 1994
Modulation of cell surface-associated mannoprotein antigen expression in experimental candidal vaginitisF De Bernardis, A Molinari, M Boccanera, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 15, 1994
Idiotypic intravaginal vaccination to protect against candidal vaginitis by secretory, yeast killer toxin-like anti-idiotypic antibodiesL Polonelli, F De Bernardis, S Conti, et al.Infection and Immunity|February 1, 1996
Elevated aspartic proteinase secretion and experimental pathogenicity of Candida albicans isolates from oral cavities of subjects infected with human immunodeficiency virusF De Bernardis, P Chiani, M Ciccozzi, et al.Pageof 23